The combined analysis of 3 trials showed that STAT3/p-STAT3 overexpression in glioma was associated with better RFS (HR = 0.37, 95%CI = 0.15 ~ 0.95, P < 0.039) (Figure 4(b)). This evidence concerns the gene STAT3 and central nervous system cancer.